CY1112723T1 - Αλας αμινης καρβοστυριλ παραγωγου - Google Patents
Αλας αμινης καρβοστυριλ παραγωγουInfo
- Publication number
- CY1112723T1 CY1112723T1 CY20121100442T CY121100442T CY1112723T1 CY 1112723 T1 CY1112723 T1 CY 1112723T1 CY 20121100442 T CY20121100442 T CY 20121100442T CY 121100442 T CY121100442 T CY 121100442T CY 1112723 T1 CY1112723 T1 CY 1112723T1
- Authority
- CY
- Cyprus
- Prior art keywords
- carbostyryl
- carbostyril
- producer
- amine
- salt amine
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Toxicology (AREA)
- Rheumatology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Pulmonology (AREA)
- Urology & Nephrology (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Quinoline Compounds (AREA)
Abstract
Η εφεύρεση αφορά σε άλας αμίνης καρβοστυρίλ παραγώγου που σχηματίζεται από καρβοστυρίλ παράγωγο που αντιπροσωπεύεται από τον τύπο (1) [όπου το R είναι άτομο αλογόνου, η υποκατεστημένη θέση της παράπλευρης αλύσου είναι 3- ή 4-θέση στο σκελετό καρβοστυριλίου και η σύνδεση μεταξύ 3- και 4- θέσης του σκελετού καρβοστυριλίου είναι απλός δεσμός ή διπλός δεσμός] και αμίνη και η εφεύρεση είναι χρήσιμη ως φάρμακα για θεραπεία διάφορων ασθενειών, πιο συγκεκριμένα ως υδατικές φαρμακοτεχνικές μορφές εξαιτίας της ανώτερης υδατοδιαλυτότητας και των ανώτερων φαρμακολογικών δράσεων.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2004013402 | 2004-01-21 | ||
EP10174397A EP2253619B1 (en) | 2004-01-21 | 2005-01-20 | Amine salt of carbostyril derivative |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1112723T1 true CY1112723T1 (el) | 2016-02-10 |
Family
ID=34805383
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20121100442T CY1112723T1 (el) | 2004-01-21 | 2012-05-11 | Αλας αμινης καρβοστυριλ παραγωγου |
CY20151100891T CY1116773T1 (el) | 2004-01-21 | 2015-10-06 | Αλας αμινης καρβοστυριλ παραγωγου |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20151100891T CY1116773T1 (el) | 2004-01-21 | 2015-10-06 | Αλας αμινης καρβοστυριλ παραγωγου |
Country Status (23)
Country | Link |
---|---|
US (2) | US7732611B2 (el) |
EP (2) | EP2253619B1 (el) |
JP (1) | JP4516962B2 (el) |
KR (1) | KR100844762B1 (el) |
CN (1) | CN1934086B (el) |
AR (1) | AR047438A1 (el) |
AT (1) | ATE549318T1 (el) |
AU (1) | AU2005206430B2 (el) |
BR (1) | BRPI0506982A (el) |
CA (1) | CA2553231C (el) |
CY (2) | CY1112723T1 (el) |
DK (2) | DK1706383T3 (el) |
ES (2) | ES2382133T3 (el) |
HK (2) | HK1101327A1 (el) |
HU (1) | HUE027990T2 (el) |
MY (1) | MY148416A (el) |
PL (2) | PL2253619T3 (el) |
PT (2) | PT1706383E (el) |
RU (1) | RU2372336C2 (el) |
SG (1) | SG149854A1 (el) |
SI (2) | SI1706383T1 (el) |
TW (1) | TWI340650B (el) |
WO (1) | WO2005070892A1 (el) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6187197B1 (en) * | 1998-10-28 | 2001-02-13 | Marvin Haddock | Multi-stage engine coolant recycling process |
TWI340650B (en) * | 2004-01-21 | 2011-04-21 | Otsuka Pharma Co Ltd | Amine saly of carbostyril derivative |
CN101778626B (zh) * | 2007-08-10 | 2014-05-07 | 大塚制药株式会社 | 含有瑞巴派特的药物组合物 |
US9486418B2 (en) * | 2008-04-08 | 2016-11-08 | Dynamis Pharmaceuticals, Inc. | Method for treating or preventing dry eye disorders using alkylamino-polyhydroxyalkanes |
DK2285413T3 (da) * | 2008-06-19 | 2012-08-27 | Otsuka Pharma Co Ltd | Farmaceutisk sammensætning |
CN103476753B (zh) * | 2011-02-25 | 2015-12-09 | 诺弗米克斯有限公司 | 新的瑞巴派特复合物和共晶体 |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS517614Y2 (el) * | 1971-02-12 | 1976-03-01 | ||
FI80022C (fi) | 1982-07-05 | 1990-04-10 | Otsuka Pharma Co Ltd | Foerfarande foer framstaellning av ett nytt, terapeutiskt anvaendbart karbostyrilderivat. |
JPS597168A (ja) | 1982-07-05 | 1984-01-14 | Otsuka Pharmaceut Co Ltd | カルボスチリル誘導体 |
CA2088582A1 (en) * | 1991-06-07 | 1992-12-08 | Katsuya Yamasaki | Anti-diabetes mellitus |
TW227558B (el) * | 1992-05-14 | 1994-08-01 | Otsuka Pharma Co Ltd | |
US5415872A (en) | 1992-06-22 | 1995-05-16 | Digestive Care Inc. | Compositions of gastric acid-resistant microspheres containing salts of bile acids |
JP2872546B2 (ja) * | 1992-11-26 | 1999-03-17 | 大塚製薬株式会社 | 腸粘膜障害保護剤 |
AU683697B2 (en) * | 1993-10-21 | 1997-11-20 | Otsuka Pharmaceutical Co., Ltd. | Carbostyril derivative for inhibiting production of interleukin-8 |
WO1995012579A1 (en) | 1993-11-05 | 1995-05-11 | Otsuka Pharmaceutical Company, Limited | Bismuth salt of carbostyril derivatives for the treatment of peptic ulcers |
JP3621463B2 (ja) | 1995-04-26 | 2005-02-16 | 大塚製薬株式会社 | カルボスチリル誘導体ビスマス塩 |
AR004214A1 (es) | 1995-10-12 | 1998-11-04 | Otsuka Pharma Co Ltd | Una preparación de gotas oftálmicas para la cura de enfermedades oftálmicas |
GB9613455D0 (en) * | 1996-06-27 | 1996-08-28 | Aston Molecules Ltd | Analogues or derivatives of quercetin |
WO2003076393A1 (en) | 2002-03-11 | 2003-09-18 | Novartis Ag | Salts of nateglinide |
KR20040104020A (ko) | 2003-06-02 | 2004-12-10 | 진양제약주식회사 | 신규 레바미피드 리지네이트와 레바미피드 아르기니네이트및 이 신규 레바미피드 리지네이트와 레바미피드아르기니네이트를 유효성분으로 함유하는 약학적 제제 |
TWI340650B (en) * | 2004-01-21 | 2011-04-21 | Otsuka Pharma Co Ltd | Amine saly of carbostyril derivative |
JP4719917B2 (ja) | 2007-03-30 | 2011-07-06 | 国立大学法人 岡山大学 | アズキ加工食品のアズキ原料品種判定方法 |
-
2005
- 2005-01-18 TW TW094101386A patent/TWI340650B/zh not_active IP Right Cessation
- 2005-01-19 MY MYPI20050200A patent/MY148416A/en unknown
- 2005-01-20 RU RU2006129945/04A patent/RU2372336C2/ru not_active IP Right Cessation
- 2005-01-20 CA CA2553231A patent/CA2553231C/en not_active Expired - Fee Related
- 2005-01-20 BR BRPI0506982-3A patent/BRPI0506982A/pt not_active IP Right Cessation
- 2005-01-20 AT AT10174397T patent/ATE549318T1/de active
- 2005-01-20 PT PT57041444T patent/PT1706383E/pt unknown
- 2005-01-20 CN CN2005800086478A patent/CN1934086B/zh not_active Expired - Fee Related
- 2005-01-20 SI SI200531992T patent/SI1706383T1/sl unknown
- 2005-01-20 PL PL10174397T patent/PL2253619T3/pl unknown
- 2005-01-20 HU HUE05704144A patent/HUE027990T2/en unknown
- 2005-01-20 DK DK05704144.4T patent/DK1706383T3/en active
- 2005-01-20 AU AU2005206430A patent/AU2005206430B2/en not_active Ceased
- 2005-01-20 EP EP10174397A patent/EP2253619B1/en not_active Not-in-force
- 2005-01-20 DK DK10174397.9T patent/DK2253619T3/da active
- 2005-01-20 ES ES10174397T patent/ES2382133T3/es active Active
- 2005-01-20 EP EP05704144.4A patent/EP1706383B1/en not_active Not-in-force
- 2005-01-20 AR ARP050100199A patent/AR047438A1/es not_active Application Discontinuation
- 2005-01-20 PL PL05704144T patent/PL1706383T3/pl unknown
- 2005-01-20 WO PCT/JP2005/001034 patent/WO2005070892A1/en active Application Filing
- 2005-01-20 SI SI200531494T patent/SI2253619T1/sl unknown
- 2005-01-20 PT PT10174397T patent/PT2253619E/pt unknown
- 2005-01-20 SG SG200900369-0A patent/SG149854A1/en unknown
- 2005-01-20 KR KR1020067016600A patent/KR100844762B1/ko active IP Right Grant
- 2005-01-20 US US10/586,453 patent/US7732611B2/en not_active Expired - Fee Related
- 2005-01-20 ES ES05704144.4T patent/ES2544327T3/es active Active
- 2005-01-20 JP JP2006520510A patent/JP4516962B2/ja active Active
-
2007
- 2007-08-24 HK HK07109247.5A patent/HK1101327A1/xx not_active IP Right Cessation
-
2010
- 2010-04-26 US US12/662,610 patent/US8222276B2/en not_active Expired - Fee Related
-
2011
- 2011-03-17 HK HK11102692.4A patent/HK1148527A1/xx not_active IP Right Cessation
-
2012
- 2012-05-11 CY CY20121100442T patent/CY1112723T1/el unknown
-
2015
- 2015-10-06 CY CY20151100891T patent/CY1116773T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1112723T1 (el) | Αλας αμινης καρβοστυριλ παραγωγου | |
CY1120081T1 (el) | Παραγωγα hydroxybenzamide σαν παραγοντες καταστολης της hsp90 | |
CY1107426T1 (el) | Νεα παραγωγα φθοριογλυκοσιδιων απο πυραζολες, φαρμακευτικα προϊοντα που περιεχουν τις εν λογω ενωσεις και η χρηση αυτων | |
CY1115533T1 (el) | Παραγωγα χολικου οξεος ως προσδετες fxr για την προληψη ή τη θεραπευτικη αγωγη νοσηματων ή καταστασεων οι οποιες προκαλουνται με τη μεσολαβηση fxr | |
CY1109677T1 (el) | Παραγωγα κινολινης και χρηση αυτων ως μυκοβακτηριακων αναστολεων | |
CY1105621T1 (el) | Νεα ετεροκυκλικα παραγωγα φθορογλυκοζιτου, φαρμακα που περιεχουν τις ενωσεις αυτες και η χρηση τους | |
CY1106894T1 (el) | Παραγωγα σουλφοναμιδιων για την αγωγη ασθενειων | |
CY1113029T1 (el) | Παραγωγα αζαδικυκλο [3.1.0] εξανιου χρησιμα ως ρυθμιστες υποδοχεων d3 ντοπαμινης | |
CY1113267T1 (el) | Παραγωγα θειοφαινιου ως αγωνιστες των υποδοσεων s1p1/edg1 | |
CY1118390T1 (el) | Θεραπευτικος παραγων για τη φλεγμονωδη νοσο του εντερου | |
ATE478044T1 (de) | Biphenylderivate und ihre verwendung bei der behandlung von hepatitis c | |
CY1112232T1 (el) | Κινολινικα παραγωγα ως αναστολεις φωσφοδιεστερασης | |
CY1110392T1 (el) | Υποκατεστημενα παραγωγα μορφολινης και θειομορφολινης | |
CY1112703T1 (el) | Υποκατεστημενες πιπεριδινο-διϋδρο-θειενο-πυριμιδινες | |
CY1106566T1 (el) | Χρηση ινδολικων και ινδολινικων παραγωγων στην αντιμετωπιση της παχυσαρκιας ή για την ελαττωση της προσληψης τροφης | |
CY1111425T1 (el) | ΠΑΡΑΓΩΓΑ ΤΗΣ ΠΥΡΙΔΟ[2,1-a]-ΙΣΟΚΙΝΟΛΙΝΗΣ ΩΣ DPP-IV ΑΝΑΣΤΟΛΕΙΣ | |
ATE517882T1 (de) | Chinolinderivate | |
CY1110520T1 (el) | Παραγωγα 5-υποκατεστημενης κινολινης και ισοκινολινης· μεθοδος για την παραγωγη τους και η χρηση τους ως αντιφλεγμονωδη | |
CY1113257T1 (el) | Παραγωγα βενζυλοπιπεραζινης τα οποια ειναι χρησιμα στη θεραπεια γαστρεντερικων διαταραχων | |
CY1108455T1 (el) | Νεος στεροειδης αγωνιστης δια fxr | |
CY1105362T1 (el) | Παραγωγα σουλφοναμιδιου, η παρασκευη τους και η εφαρμογη αυτων ως φαρμακα | |
CY1112826T1 (el) | [4-(6-αλογονο-7-υποκατεστημενες-2,4-διοξο-1,4-διϋδρο-2η-κιναζολιν-3-υλ)-φαινυλ]-5-χλωρο-θειοφαιν-2-υλ-σουλφονυλουριες και μορφες και μεθοδοι που σχετιζονται με αυτες | |
CY1106003T1 (el) | Παραγωγα του ν-βενζοϋλοουρεϊδο-κινναμωμικου οξεος, μεθοδος για την παρασκευη τους και η χρηση τους | |
ATE449776T1 (de) | Pyrroloä2,3-cüpyridinderivate | |
EA200700997A1 (ru) | 2,5- и 2,6-дизамещенные аналоги бензазола, полезные в качестве ингибиторов протеинкиназ |